Loading...

343 posters, 5 videos, 2 audios, 18 topics, 33 sessions, 263 authors, 202 institutions

ePostersLive by SciGen Technologies S.A. All rights reserved.

24th Annual Pain Medicine Meeting 2025

November 13-15, 2025| JW Marriott Austin, Austin, Texas

24th Annual Pain Medicine Meeting 2025 banner

2184964

Safety Considerations for Performing Radiofrequency Ablation in Patients with Deep Brain Stimulators

Poster Presenter

Gabriel Augustin

Part of Topic

Safety/QA/QI Projects

INTRODUCTION

Radiofrequency ablation (RFA) is a widely utilized interventional technique for managing chronic axial pain, particularly in the cervical and lumbar regions. However, limited data exist regarding the safety of RFA in patients with implanted neurostimulators such as deep brain stimulators (DBS) where risks include electromagnetic interference (EMI), thermal injury, and device malfunction.

 

Furthermore, this presentation aims to provide evidence-based safety strategies regarding the three procedural phases for performing RFA in patients with DBS.

 

 

METHODS

As the case report is devoid of patient identifiable information, it is exempt from IRB review requirements as per Henry Ford Hospital's policy


 

Case Report:

 

 

 

This is a case of a 71-year-old male with the PMHx of lumbosacral spondylosis, Parkinson's disease s/p deep brain stimulator (DBS) placement (04/2024), CAD s/p LAD stent 2024 (currently on DAPT), and type 2 DM.

 

 

 

The patient was referred to our Pain Clinic for a bilateral L3, L4 medial branch and bilateral L5 dorsal root primary ramus radiofrequency ablation under fluoroscopic guidance. 

 

 

 

On the day of his procedure, the patient’s DBS device was neither interrogated nor deactivated prior to the intervention. Additionally, the DBS device representative was not contacted.

 

 

 

Prior to starting the procedure, the interventionalist performed a rapid literature review and found that it is recommended to place the grounding pad on the contralateral side of the DBS, however they were unable to find any additional recommendations.   

 

 Preprocedural recommendations and

guidelines:

  •  

  • Consult device representative

  •  

  • Multidisciplinary consult with Neurology + Neurosurgery

  •  

  • Preprocedural DBS device interrogation

  •  

  • DBS deactivation for approximately 30 minutes can serve as a clinical trial to assess the patient’s tolerance and anticipated neurologic status during the procedure

 

Intraprocedural recommendations and guidelines:

  •  

  • Appropriate adjustment of power settings and lesion time

  •  

  • Bipolar RFA preferred over monopolar RFA

  •  

  • Place the RFA cannula more than 6 inches from the internal pulse generator and its leads to avoid EMI interference

 

  • If using Monopolar RFA utilize contralateral grounding pad placement

 

Postprocedural recommendations and guidelines:

 

  • Postprocedural device interrogation

  •  

  • Evaluate for pain, warmth, or swelling over the pulse generator + lead tracts (could indicate thermal injury)

 

 

 

DISCUSSION

Key points

  • RFA should always be performed with the DBS turned off

  • Grounding pad on the contralateral side + placed far away from the pulse generator and leads

  • Lowest effective power and lesion time

  • Evaluate DBS site and lead tracts for signs of thermal injury

  •  

  •  

REFERENCES

  • Banik RK, Peng S, Kohan L, Rana P, Darrow DP, Hagedorn JM.
    Radiofrequency ablation of lumbar medial branch nerves in a patient with a deep brain stimulator: Our experience and literature review.
    Pain Medicine. 2023;24(6):734–737. doi:10.1093/pm/pnac179

  •  

  • Grabie M, Gabriels J, Xiang K, Elayi CS, Makaryus JN, Catanzaro JN.
    Feasibility of radiofrequency catheter ablation in a patient with deep brain stimulators.
    HeartRhythm Case Reports. 2020;6(5):253–255. doi:10.1016/j.hrcr.2020.01.005

 

  • Krishnan S, Pisharady K.
    Surgical treatment of levodopa-induced dyskinesia in Parkinson’s disease.
    Annals of Indian Academy of Neurology.2017;20:199–206. doi:10.4103/aian.AIAN_244_17

 

 

 



24th Annual Pain Medicine Meeting 2025 banner
Copyright © 2015-2026, ePostersLive® SciGen is a registered trademark of SciGen Technologies S.A. Patent pending.

This website and third-party tools we use rely on cookies for the best user experience. By selecting "I agree", you agree to cookie usage as described in our Privacy Policy.